Your browser doesn't support javascript.
loading
Treatment of "poor risk" acute nonlymphocytic leukemia with continuously infused low-dose cytosine arabinoside.
Balaban, E P; Cox, J V; Schneider, N R; Harth, C A; Haley, B B; Sheehan, R; Frenkel, E P.
Affiliation
  • Balaban EP; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235.
Am J Hematol ; 29(2): 79-84, 1988 Oct.
Article in En | MEDLINE | ID: mdl-3189306
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cytarabine Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male Language: En Journal: Am J Hematol Year: 1988 Document type: Article
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cytarabine Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male Language: En Journal: Am J Hematol Year: 1988 Document type: Article